The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population

Abstract Background The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA). Guidelines show that plasma aldosterone is normally suppressed by captopril (> 30%) in primary hypertension (PH) and in healthy people. It is unclear whether this...

Full description

Bibliographic Details
Main Authors: Ke-ying Zhu, Yan Zhang, Wen-jing Zhang, Hong-yun Li, Wen-huan Feng, Da-long Zhu, Ping Li
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12902-019-0390-3
id doaj-343618e11f3441cb9bf704b57b16854d
record_format Article
spelling doaj-343618e11f3441cb9bf704b57b16854d2020-11-25T03:37:05ZengBMCBMC Endocrine Disorders1472-68232019-06-011911710.1186/s12902-019-0390-3The captopril challenge test for diagnosing primary Aldosteronism in a Chinese populationKe-ying Zhu0Yan Zhang1Wen-jing Zhang2Hong-yun Li3Wen-huan Feng4Da-long Zhu5Ping Li6Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing Medical University SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolAbstract Background The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA). Guidelines show that plasma aldosterone is normally suppressed by captopril (> 30%) in primary hypertension (PH) and in healthy people. It is unclear whether this standard is applicable in Chinese subjects. The aim of the present study was to investigate the post-CCT efficacy of plasma aldosterone concentration (PAC) suppression and determine the post-CCT aldosterone renin activity ratio (ARR) and PAC for PA diagnosis. Methods We recruited 110 consecutive patients with PA, 163 with primary hypertension (PH), and 40 healthy volunteers (NC). The CCT was conducted in all patients. Total sodium intake was estimated from 24-h urinary excretions. ROC curves were used to analyze the efficiency of different CCT diagnostic criteria for diagnosing PA. Results In NC and PH patients, PRA was increased and PAC was decreased post-CCT (P < 0.05). The mean degree of PAC decline after CCT was approximately 9.3%, and only 11.7% of the patients with PH showed a greater than 30% suppression of PAC after CCT. In patients with PA, the post-CCT change in PRA and PRC was slight. The post-CCT degree of PAC decline was unrelated to dietary salt intake. The areas under the ROC for the post-CCT ARR, PAC and PAC suppression % were 0.994, 0.754 and 0.606, respectively. The optimal post-CCT cutoff value for ARR for diagnosing PA was 20, which yielded a sensitivity and specificity of 94.0 and 99.4%, respectively. Conclusions The PAC suppression percentage after CCT recommended by current clinical guidelines is not applicable when diagnosing Chinese subjects with PA. Compared to post-CCT PAC, post-CCT ARR was a better approach, having an optimal cutoff of 20 when interpreting the results of the CCT in Chinese patients. We found no relationship between high salt intake and low responses of the renin-angiotensin system (RAS) to the CCT.http://link.springer.com/article/10.1186/s12902-019-0390-3Primary aldosteronismDiagnosisCaptopril challenge test
collection DOAJ
language English
format Article
sources DOAJ
author Ke-ying Zhu
Yan Zhang
Wen-jing Zhang
Hong-yun Li
Wen-huan Feng
Da-long Zhu
Ping Li
spellingShingle Ke-ying Zhu
Yan Zhang
Wen-jing Zhang
Hong-yun Li
Wen-huan Feng
Da-long Zhu
Ping Li
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
BMC Endocrine Disorders
Primary aldosteronism
Diagnosis
Captopril challenge test
author_facet Ke-ying Zhu
Yan Zhang
Wen-jing Zhang
Hong-yun Li
Wen-huan Feng
Da-long Zhu
Ping Li
author_sort Ke-ying Zhu
title The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
title_short The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
title_full The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
title_fullStr The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
title_full_unstemmed The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
title_sort captopril challenge test for diagnosing primary aldosteronism in a chinese population
publisher BMC
series BMC Endocrine Disorders
issn 1472-6823
publishDate 2019-06-01
description Abstract Background The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA). Guidelines show that plasma aldosterone is normally suppressed by captopril (> 30%) in primary hypertension (PH) and in healthy people. It is unclear whether this standard is applicable in Chinese subjects. The aim of the present study was to investigate the post-CCT efficacy of plasma aldosterone concentration (PAC) suppression and determine the post-CCT aldosterone renin activity ratio (ARR) and PAC for PA diagnosis. Methods We recruited 110 consecutive patients with PA, 163 with primary hypertension (PH), and 40 healthy volunteers (NC). The CCT was conducted in all patients. Total sodium intake was estimated from 24-h urinary excretions. ROC curves were used to analyze the efficiency of different CCT diagnostic criteria for diagnosing PA. Results In NC and PH patients, PRA was increased and PAC was decreased post-CCT (P < 0.05). The mean degree of PAC decline after CCT was approximately 9.3%, and only 11.7% of the patients with PH showed a greater than 30% suppression of PAC after CCT. In patients with PA, the post-CCT change in PRA and PRC was slight. The post-CCT degree of PAC decline was unrelated to dietary salt intake. The areas under the ROC for the post-CCT ARR, PAC and PAC suppression % were 0.994, 0.754 and 0.606, respectively. The optimal post-CCT cutoff value for ARR for diagnosing PA was 20, which yielded a sensitivity and specificity of 94.0 and 99.4%, respectively. Conclusions The PAC suppression percentage after CCT recommended by current clinical guidelines is not applicable when diagnosing Chinese subjects with PA. Compared to post-CCT PAC, post-CCT ARR was a better approach, having an optimal cutoff of 20 when interpreting the results of the CCT in Chinese patients. We found no relationship between high salt intake and low responses of the renin-angiotensin system (RAS) to the CCT.
topic Primary aldosteronism
Diagnosis
Captopril challenge test
url http://link.springer.com/article/10.1186/s12902-019-0390-3
work_keys_str_mv AT keyingzhu thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT yanzhang thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT wenjingzhang thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT hongyunli thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT wenhuanfeng thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT dalongzhu thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT pingli thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT keyingzhu captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT yanzhang captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT wenjingzhang captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT hongyunli captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT wenhuanfeng captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT dalongzhu captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
AT pingli captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation
_version_ 1724547301779701760